✦ LIBER ✦
Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer
✍ Scribed by Bradley J. Monk; Ernest Han; Carol A. Josephs-Cowan; Gordon Pugmire; Robert A. Burger
- Book ID
- 113960644
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 135 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.